Literature DB >> 12215481

Endothelin antagonists and hypertension: a question of dose?

Jane Goddard, David J Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12215481     DOI： 10.1161/01.hyp.0000028980.24709.68

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  6 in total

1.  Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.

Authors:  N F Kelland; D J Webb
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

2.  Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.

Authors:  S J Leslie; J C S Spratt; S P McKee; F E Strachan; D E Newby; D B Northridge; M A Denvir; D J Webb
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

3.  Endogenous endothelin-1 and femoral artery shear rate: impact of age and implications for atherosclerosis.

Authors:  Joel D Trinity; Zachary Barrett-O'Keefe; Stephen J Ives; Garrett Morgan; Matthew J Rossman; Anthony J Donato; Sean Runnels; David E Morgan; Benjamin S Gmelch; Amber D Bledsoe; Russell S Richardson; D Walter Wray
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

4.  Taming the "sleeping giant": the role of endothelin-1 in the regulation of skeletal muscle blood flow and arterial blood pressure during exercise.

Authors:  Zachary Barrett-O'Keefe; Stephen J Ives; Joel D Trinity; Garrett Morgan; Matthew J Rossman; Anthony J Donato; Sean Runnels; David E Morgan; Benjamin S Gmelch; Amber D Bledsoe; Russell S Richardson; D Walter Wray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-26       Impact factor: 4.733

5.  Endothelin-A-mediated vasoconstriction during exercise with advancing age.

Authors:  Zachary Barrett-O'Keefe; Stephen J Ives; Joel D Trinity; Garrett Morgan; Matthew J Rossman; Anthony J Donato; Sean Runnels; David E Morgan; Benjamin S Gmelch; Amber D Bledsoe; Russell S Richardson; D Walter Wray
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05-12       Impact factor: 6.053

Review 6.  Endothelin antagonism and its role in the treatment of hypertension.

Authors:  Rebecca C Moorhouse; David J Webb; David C Kluth; Neeraj Dhaun
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.